Publications
Publications
Show Results For
- All HBS Web
(1,397)
- Faculty Publications (414)
- June 1997
- Case
Massachusetts General Hospital: CABG Surgery (B)
By: Steven C. Wheelwright and Mikelle Eastley
Once the CABG care path is implemented and other care paths begun, hospital staff and administration examine the resulting data. Further methods of improving care and reducing cost are presented for analysis. View Details
- February 1997 (Revised December 1997)
- Case
Arbor Health Care Company
By: Myra M. Hart and Stephanie Dodson
A venture-funded start-up runs into trouble when health care reimbursement policies change radically. With the help of its board, the company develops a new strategy, becomes profitable, and makes a public offering. The second wave of changes introduced by Clinton... View Details
- April 1996 (Revised June 2001)
- Case
Partners HealthCare System, Inc. (B): Cardiac Care Improvement
By: Gary P. Pisano and Maryam Golnaraghi
Explores the challenges confronting the CEO at the Brigham and Women's Hospital in the wake of radical changes in the health care environment. As pressures have risen for cost containment in health care, the hospital has embarked on a series of reengineering efforts to... View Details
- September 1995
- Case
Ares-Serono
By: Michael Y. Yoshino, Jean-Pierre Jeannet and Carin-Isabel Knoop
Ares Serono, a medium-size Swiss pharmaceutical company, is the global leader in the field of fertility drugs. The company has successfully transformed into one of the very few biotech firms in Europe. The case treats a set of major strategic and organizational... View Details
Keywords: Geographic Location; Globalized Firms and Management; Asset Management; Balance and Stability; Expansion; Digital Platforms; Leadership Development; Health Care and Treatment; Transformation; Family Business; Problems and Challenges; Pharmaceutical Industry; Biotechnology Industry; Switzerland; Europe
- June 1995
- Case
Quorum Health Group, Inc.
By: William A. Sahlman and Jason Green
Facing increasing competition from much larger industry players, Jim Dalton, CEO of Quorum, and Russ Carson, Managing Partner of Welch, Carson, Anderson & Stowe attempt to set the future direction for Quorum. The company was successfully spun-off from HCA in a... View Details
- April 1995 (Revised August 1995)
- Case
Empire Blue Cross and Blue Shield (A)
By: Regina E. Herzlinger and Ramona Hilgenkamp
Mounting financial losses and increasing public scrutiny present many challenges to the board of directors of a large nonprofit health insurer. This case series presents chronologically the increasing problems of the company. View Details
- fall 1994
- Article
Racing to Invest? The Dynamics of Competition in Ethical Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
- May 1994 (Revised February 2021)
- Background Note
Note on Reimbursement of Health Care Providers: Case-Based and Capitation Payment
By: Regina E. Herzlinger and Tom Nagle
Explains how managed care organizations use capitation as a payment method for providers. View Details
- March 1994 (Revised December 2014)
- Case
Humana, Inc.: Managing in a Changing Industry
By: Stuart Gilson
Intensifying competition and change in the U.S. health care industry force a large integrated health-care provider to reassess its strategy of operating both hospitals and health insurance plans (HMOs). In an attempt to increase its stock price and operating... View Details
- February 27, 1994
- Article
Innovation: Medicine's Best Cost-Cutter
By: M. E. Porter, Elizabeth Teisberg and Gregory Brown
- December 1993 (Revised March 1995)
- Case
Medical Products Co.
By: Robert H. Hayes
In early 1990, the company is contemplating changes in its European plant network for producing hypodermic products, including the total production capacity to be provided, the number and location of plants over which to spread this capacity, and which products should... View Details
- October 1993 (Revised July 1994)
- Case
A Brush with AIDS (A)
By: Joseph L. Badaracco Jr. and Jerry Useem
A product manager at a health products company is responsible for marketing sharps containers, which hospitals use to store used needles in order to protect medical workers from being pricked with AIDS-contaminated needles. After hospitals report repeated instances of... View Details
- August 1993
- Article
Transaction Cost Theory: Inferences from Clinical Field Research
- March 1993 (Revised June 1995)
- Case
Singapore TradeNet: The Tale Continues
By: Lynda M. Applegate, John L. King and Boon-Siong Neo
Continues the story of Singapore Network Services Pte. Ltd. (SNS), which was created to initiate and manage the creation of value-added networks for trade and other aspects of commerce in the island nation of Singapore. SNS built on its TradeNet experience to develop... View Details
- March 1993
- Supplement
Burroughs Wellcome and AZT (B)
Describes Burroughs Wellcome's response to protests over the pricing of its AIDS drug AZT in September 1989. Also presents short-term reactions by government officials, AIDS activists, and investors to Burroughs Wellcome's strategy. View Details
- February 1992 (Revised September 2003)
- Case
Beech-Nut Nutrition Corporation (A-1)
By: Lynn S. Paine
The CEO of Beech-Nut Nutrition Corp. must decide what to do when he receives information that the company's supply of apple juice concentrate may be adulterated. The concentrate is used in many of the company's juice products. It appears that others in the company may... View Details
- September 1991 (Revised February 1993)
- Case
Burroughs Wellcome and AZT (A)
Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S.... View Details
- February 1990 (Revised March 1990)
- Case
Quantum Semiconductor, Inc.
By: Janice H. Hammond and Roy D. Shapiro
Quantum is faced with a difficult ethical dilemma--industry studies provide evidence that chemicals used in semiconductor manufacturing may cause women working in fabrication cleanrooms to suffer a higher likelihood of spontaneous abortions. The possibility of other... View Details
Keywords: Safety; Prejudice and Bias; Law; Equality and Inequality; Cost; Production; Ethics; Health; Gender; Semiconductor Industry
- 1990
- Chapter
Analysis of Cost Variances for Management Control in Hospitals
By: S. Datar, R. Banker and S. Das